BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.805
EU - Europa 6.119
AS - Asia 5.107
SA - Sud America 667
Continente sconosciuto - Info sul continente non disponibili 219
AF - Africa 127
OC - Oceania 21
Totale 25.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.600
IT - Italia 2.010
GB - Regno Unito 1.948
CN - Cina 1.336
SG - Singapore 1.285
HK - Hong Kong 647
VN - Vietnam 506
BR - Brasile 481
SE - Svezia 439
DE - Germania 342
BD - Bangladesh 302
TR - Turchia 276
UA - Ucraina 240
FI - Finlandia 232
RU - Federazione Russa 224
FR - Francia 221
IN - India 178
KR - Corea 166
CA - Canada 98
BG - Bulgaria 88
NL - Olanda 73
AR - Argentina 63
MX - Messico 54
IQ - Iraq 50
JP - Giappone 50
IE - Irlanda 49
ID - Indonesia 46
ES - Italia 39
PK - Pakistan 36
PL - Polonia 34
IR - Iran 33
ZA - Sudafrica 33
CO - Colombia 29
BE - Belgio 28
RO - Romania 28
AE - Emirati Arabi Uniti 26
EC - Ecuador 25
MY - Malesia 20
VE - Venezuela 19
CH - Svizzera 17
EG - Egitto 17
IL - Israele 17
CL - Cile 16
LT - Lituania 16
UZ - Uzbekistan 16
AU - Australia 15
DZ - Algeria 15
MA - Marocco 14
SA - Arabia Saudita 14
GR - Grecia 13
CZ - Repubblica Ceca 12
JO - Giordania 12
PY - Paraguay 12
KE - Kenya 11
PT - Portogallo 11
KZ - Kazakistan 10
PH - Filippine 10
TN - Tunisia 10
TW - Taiwan 10
EU - Europa 9
AZ - Azerbaigian 8
CR - Costa Rica 8
HN - Honduras 8
JM - Giamaica 8
PE - Perù 8
RS - Serbia 8
AT - Austria 7
HU - Ungheria 7
UY - Uruguay 7
BO - Bolivia 6
DK - Danimarca 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
KH - Cambogia 5
NO - Norvegia 5
OM - Oman 5
AL - Albania 4
BY - Bielorussia 4
BZ - Belize 4
EE - Estonia 4
LK - Sri Lanka 4
NG - Nigeria 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
CY - Cipro 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
Totale 24.823
Salva come PNG Salva come JPEG
Città #
Southend 1.526
Ashburn 1.275
Fairfield 1.079
Santa Clara 1.050
Singapore 787
Woodbridge 706
Chandler 649
Hong Kong 638
Houston 462
Jacksonville 458
Seattle 446
Wilmington 444
Chicago 426
San Jose 426
Dearborn 387
Ann Arbor 379
Cambridge 375
Beijing 337
Hefei 331
Council Bluffs 318
Nyköping 282
Los Angeles 262
Modena 236
London 229
Ho Chi Minh City 177
Izmir 158
Helsinki 146
Milan 143
New York 140
The Dalles 136
Seoul 121
Salt Lake City 99
Rome 93
Hanoi 92
Princeton 91
San Diego 84
Sofia 83
Eugene 80
Dallas 70
Buffalo 68
Columbus 66
Lauterbourg 62
Moscow 58
Bologna 57
Redwood City 53
Fremont 48
Elk Grove Village 47
Falls Church 47
Shanghai 47
São Paulo 46
Tampa 45
Orem 42
Tokyo 42
Phoenix 39
Chennai 38
Munich 36
Bremen 35
Dublin 35
Frankfurt am Main 34
Naples 32
Jakarta 28
Como 27
Florence 27
Napoli 26
Palermo 25
Brussels 24
Des Moines 24
Guangzhou 24
Lancaster 23
Reggio Emilia 23
San Giuliano Milanese 22
Da Nang 21
Tulare 21
Mexico City 20
Brooklyn 18
Catania 18
Miami 18
Montreal 18
Sterling 18
Toronto 18
Warsaw 18
Atlanta 17
Baghdad 17
Boardman 17
Genoa 17
Manchester 17
Bari 16
Johannesburg 16
Norwalk 16
Parma 16
Stockholm 16
Kocaeli 15
Nanjing 15
New Delhi 15
Turin 15
Perugia 14
Biên Hòa 13
Boston 13
Cairo 13
Dulles 13
Totale 16.950
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 603
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 519
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 489
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 454
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 444
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 428
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 426
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 420
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 414
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 412
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 408
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 404
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 398
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 387
Nanoparticle transport across the blood brain barrier 375
Nanomedicine: the future for advancing medicine and neuroscience 373
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 373
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 372
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 371
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 369
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 369
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 366
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 364
Protein corona and nanoparticles: How can we investigate on? 363
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 354
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 352
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 351
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 349
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 344
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 340
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 339
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 337
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 337
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 337
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 332
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 328
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 328
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 328
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 323
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 315
Functionalization of liposomes: microscopical methods for preformulative screening 314
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 311
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 310
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 302
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 299
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 277
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 275
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 274
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 268
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 266
Immunonanosystems to CNS pathologies: State of the art 263
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 260
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 260
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 258
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 256
Nanotechnology and Central Nervous System Drug Delivery 256
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 254
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 252
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 250
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 245
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 243
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 237
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 236
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 233
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 231
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 221
Leptin-conjugated nanoparticles as drug delivery system to the brain 219
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 219
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 216
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 206
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 196
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 195
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 185
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 184
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 181
Nanomedicine in neurodegenerative disorders: Understanding the journey 173
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 171
Nanotechnology in medicine: therapeutic strategies in neurological disorders 150
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 146
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 133
Totale 25.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.437 0 0 169 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.333 72 66 91 98 298 139 145 172 37 39 59 117
2024/20253.723 170 54 62 287 765 520 279 307 335 161 354 429
2025/20267.232 436 214 456 876 1.382 473 738 330 698 731 444 454
2026/2027638 159 452 27 0 0 0 0 0 0 0 0 0
Totale 25.065